475 related articles for article (PubMed ID: 29374630)
21. Myeloid DJ-1 deficiency protects acetaminophen-induced acute liver injury through decreasing inflammatory response.
Wang B; Li J; Jiao J; Xu M; Luo Y; Wang F; Xia Q; Gao Y; Feng Y; Kong X; Sun X
Aging (Albany NY); 2021 Jul; 13(14):18879-18893. PubMed ID: 34289451
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of triggering receptors expressed on myeloid cells-1 with the oncogenesis and progression of hepatocellular carcinoma].
Li W; Zhang N; Ou Y; Zhou Z; Zhao F; Wu Q; Yang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1705-9, 1720. PubMed ID: 26714901
[TBL] [Abstract][Full Text] [Related]
23. Function of TREM1 and TREM2 in Liver-Related Diseases.
Sun H; Feng J; Tang L
Cells; 2020 Dec; 9(12):. PubMed ID: 33297569
[TBL] [Abstract][Full Text] [Related]
24. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
25. Role of triggering receptor expressed on myeloid cells-1/3 in Klebsiella-derived pneumosepsis.
Hommes TJ; Dessing MC; Veer Cv; Florquin S; Colonna M; de Vos AF; van der Poll T
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):647-55. PubMed ID: 25860078
[TBL] [Abstract][Full Text] [Related]
26. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
[TBL] [Abstract][Full Text] [Related]
27. Blockade of Notch signaling promotes acetaminophen-induced liver injury.
Jiang L; Ke M; Yue S; Xiao W; Yan Y; Deng X; Ying QL; Li J; Ke B
Immunol Res; 2017 Jun; 65(3):739-749. PubMed ID: 28286920
[TBL] [Abstract][Full Text] [Related]
28. Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis.
Weehuizen TA; Hommes TJ; Lankelma JM; de Jong HK; Roelofs JJ; de Vos AF; Colonna M; van der Poll T; Wiersinga WJ
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004747. PubMed ID: 27253382
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.
Hamerman JA; Jarjoura JR; Humphrey MB; Nakamura MC; Seaman WE; Lanier LL
J Immunol; 2006 Aug; 177(4):2051-5. PubMed ID: 16887962
[TBL] [Abstract][Full Text] [Related]
30. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
31. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia.
Hommes TJ; Hoogendijk AJ; Dessing MC; Van't Veer C; Florquin S; Colonna M; de Vos AF; van der Poll T
J Pathol; 2014 Aug; 233(4):357-67. PubMed ID: 24752755
[TBL] [Abstract][Full Text] [Related]
32. The role of TREM-2 in internalization and intracellular survival of Brucella abortus in murine macrophages.
Wei P; Lu Q; Cui G; Guan Z; Yang L; Sun C; Sun W; Peng Q
Vet Immunol Immunopathol; 2015 Feb; 163(3-4):194-201. PubMed ID: 25563793
[TBL] [Abstract][Full Text] [Related]
33. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.
Wu M; Peng A; Sun M; Deng Q; Hazlett LD; Yuan J; Liu X; Gao Q; Feng L; He J; Zhang P; Huang X
Infect Immun; 2011 Jul; 79(7):2709-16. PubMed ID: 21555403
[TBL] [Abstract][Full Text] [Related]
34. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands.
Zheng H; Heiderscheidt CA; Joo M; Gao X; Knezevic N; Mehta D; Sadikot RT
Eur J Immunol; 2010 Jan; 40(1):162-71. PubMed ID: 19904768
[TBL] [Abstract][Full Text] [Related]
35. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
Molad Y; Pokroy-Shapira E; Carmon V
Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
[TBL] [Abstract][Full Text] [Related]
36. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.
Amatngalim GD; Nijnik A; Hiemstra PS; Hancock RE
Inflammation; 2011 Oct; 34(5):412-25. PubMed ID: 20811938
[TBL] [Abstract][Full Text] [Related]
37. TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.
Yuan Z; Syed M; Panchal D; Joo M; Bedi C; Lim S; Onyuksel H; Rubinstein I; Colonna M; Sadikot RT
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(5):L426-38. PubMed ID: 26684249
[TBL] [Abstract][Full Text] [Related]
38. The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia.
Sharif O; Gawish R; Warszawska JM; Martins R; Lakovits K; Hladik A; Doninger B; Brunner J; Korosec A; Schwarzenbacher RE; Berg T; Kralovics R; Colinge J; Mesteri I; Gilfillan S; Salmaggi A; Verschoor A; Colonna M; Knapp S
PLoS Pathog; 2014 Jun; 10(6):e1004167. PubMed ID: 24945405
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the TREM-1-TLR connection.
Klesney-Tait J; Colonna M
Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1374-6. PubMed ID: 17934061
[No Abstract] [Full Text] [Related]
40. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
